• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Digital Diabetes Market to Reach $1.5B by 2024, Research Finds

by Jasmine Pennic 12/14/2020 Leave a Comment

Diabetes Management Apps Global Mobile Health Solutions_7 Best Practices for Developing Successful Diabetes Mobile Apps

What You Should Know: - The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.  - Digital diabetes solutions have disrupted the
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy

by Fred Pennic 10/21/2020 Leave a Comment

Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy

What You Should Know:   - Babyscripts today announced a commercial partnership with Roche Diagnostics, a division of the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics.  - Roche will partner with Babyscripts on the development of Babyscripts’ remote patient monitoring (RPM) programs to leverage groundbreaking data science through the next generation of RPM in pregnancy.  Babyscripts, a Washington D.C.-based
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Corindus Vascular Robotics CEO Departure, UPMC Enterprises’ New President, Nordic Consulting’s New CIO, Other Health IT Hires

by Fred Pennic 09/18/2020 Leave a Comment

Tele-Treatment: How We Close the Gap in Access to Care

Mark Toland, Partner, Biostar Capital Mark Toland, CEO of Corindus Vascular Robotics (acquired by Siemens for $1.1B last year), has announced his departure and will be joining BioStar Capital, a health-tech venture capital group focused on cardiovascular and orthopedic medical devices. As a partner and entrepreneur in residence, Mark will help to identify and develop innovative companies leveraging AI, deep learning, robotics, and other transformative technologies that address a wide range of
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments

by Fred Pennic 09/11/2020 Leave a Comment

Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments

Evidation, Co-CEO, Christine Lemke  Evidation’s Board of Directors has appointed Christine Lemke as Co-CEO alongside Executive Chair Deborah Kilpatrick. Pratap Sarker, President, Greenway Health Greenway Health appoints Pratap Sarker as President to oversee all commercial and customer-focused functions including sales, marketing, and customer success. He will also work closely with Greenway’s clearinghouse, revenue cycle and IT teams to ensure the delivery of quality solutions
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

by Jasmine Pennic 09/02/2020 Leave a Comment

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

What You Should Know: - Medtronic announced the U.S. Food and Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump system with smartphone connectivity and an expanded age indication to patients with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for an automated insulin pump system.  - The new MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app (compatible with both iPhone and Android), and Roche Accu-Chek®
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

by Fred Pennic 05/28/2020 Leave a Comment

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San Francisco, CA-based provider of precision oncology solutions announced $30
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

2020 MedTech Breakthrough Award Winners Announced

by Fred Pennic 05/21/2020 Leave a Comment

2020 MedTech Breakthrough Award Winners Announced

What You Should Know: - MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today. - The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services.  MedTech Breakthrough, a market intelligence organization that
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

In-Depth: 32 FDA-Approved COVID-19 Testing Kits

by Kayla Matthews 04/23/2020 Leave a Comment

FDA Approves COVID-19 Oral Fluid Test for Use Nationwide

What You Should Know: - In-depth look list of FDA-approved COVID-19 test kits The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.  The FDA makes a
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

by Simon Harris, Managing Director at Signify Research 03/09/2020 Leave a Comment

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market: - The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio. - TeraRecon is an Advanced
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

by Jasmine Pennic 06/11/2019 Leave a Comment

Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).The Cancer Genome Atlas (TCGA) Project BackgroundThere are 230 distinct investigators that contributed
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • Philips Acquires Medical Device Integration Platform Capsule for $635M Philips Acquires Medical Device Integration Platform Capsule for $635M
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 20 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • DPHO, UnitedHealthcare Launch Accountable Care Program UnitedHealth Rolls Out Employer Virtual Primary Care Plan
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |